neuroscience
AxoSim acquires Vyant’s organoid tech for brain disorder research
Anika Sharma
AxoSim, a New Orleans-based drug discovery biotech, has successfully completed the acquisition of the neuroscience research assets from Vyant Bio’s ...
Novartis halts depression drug trial, putting $210M Cadent buyout at risk
Anika Sharma
Novartis has made the decision to discontinue a mid-phase program aimed at treating major depressive disorder (MDD) with the investigational ...
